Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥3,933,161 | CN¥3,936,711 | CN¥5,408,625 | CN¥9,121,030 |
| - Cash | CN¥158,727 | CN¥226,608 | CN¥467,619 | CN¥912,019 |
| + Debt | CN¥969,583 | CN¥917,806 | CN¥863,011 | CN¥840,566 |
| Enterprise Value | CN¥4,744,016 | CN¥4,627,908 | CN¥5,804,018 | CN¥9,049,577 |
| Revenue | CN¥1,443,365 | CN¥1,541,939 | CN¥1,786,428 | CN¥1,930,602 |
| % Growth | -6.4% | -13.7% | -7.5% | – |
| Gross Profit | CN¥596,185 | CN¥623,759 | CN¥933,854 | CN¥931,331 |
| % Margin | 41.3% | 40.5% | 52.3% | 48.2% |
| EBITDA | CN¥170,417 | CN¥163,985 | CN¥337,302 | CN¥305,118 |
| % Margin | 11.8% | 10.6% | 18.9% | 15.8% |
| Net Income | CN¥55,441 | CN¥49,209 | CN¥93,260 | CN¥166,510 |
| % Margin | 3.8% | 3.2% | 5.2% | 8.6% |
| EPS Diluted | 0.091 | 0.08 | 0.152 | 0.27 |
| % Growth | 13.7% | -47.4% | -43.7% | – |
| Operating Cash Flow | CN¥120,222 | -CN¥72,870 | -CN¥239,648 | CN¥22,085 |
| Capital Expenditures | -CN¥88,430 | -CN¥128,724 | -CN¥167,231 | -CN¥277,060 |
| Free Cash Flow | CN¥31,792 | -CN¥201,594 | -CN¥406,880 | -CN¥254,974 |